Triple therapy improves cystic fibrosis in children 2-11
Medical Xpress1 min read96 words
Cystic fibrosis is an incurable genetic disorder. Since 2020, a treatment known as triple therapy has addressed the underlying cause of the disease.
Researchers at Charité – Universitätsmedizin Berlin found that the therapy is particularly effective in early childhood: molecular channels in the mucous membranes, which do not function or function poorly in people with cystic fibrosis, reached nearly normal functional levels in children ages 2 to 11 following treatment.
The therapy, known as triple therapy, has been effective in children ages 2 to 11, bringing molecular channels in mucous membranes to nearly normal functional levels.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.